Product NDC: | 10337-395 |
Proprietary Name: | ApexiCon E |
Non Proprietary Name: | diflorasone diacetate |
Active Ingredient(s): | .5 mg/g & nbsp; diflorasone diacetate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10337-395 |
Labeler Name: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076263 |
Marketing Category: | ANDA |
Start Marketing Date: | 20021220 |
Package NDC: | 10337-395-60 |
Package Description: | 1 TUBE in 1 CARTON (10337-395-60) > 60 g in 1 TUBE |
NDC Code | 10337-395-60 |
Proprietary Name | ApexiCon E |
Package Description | 1 TUBE in 1 CARTON (10337-395-60) > 60 g in 1 TUBE |
Product NDC | 10337-395 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | diflorasone diacetate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20021220 |
Marketing Category Name | ANDA |
Labeler Name | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
Substance Name | DIFLORASONE DIACETATE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |